Lymphovenous Canada: Volunteers wanted for London Ontario's Lymphdiaral Study

The Lymphdiaral Study and involves a 12 week trial of a homeopathic cream and oral drops taken by mouth in water. The study subjects will be randomized to one of two treatment arms. Arm 1 receives the standard therapy of a compression sleeve and Arm 2 receives standard therapy plus the Lymphdiaral preparations. Cost of the Lymphdiaral is covered - the sleeves are funded as usual practice by the ADP program.

To be eligible you must have been diagnosed with breast cancer and have completed all treatments. In order to measure effect, patients must have at least 200 ml of fluid excess in the affected arm. This is assessed at the first visit. Patients with metastatic disease are not eligible. If a patient has been previously treated for lymphedema they are also not eligible.

The study involves 12 weeks of active treatment and 12 weeks of observation. In the first 12 weeks patients attend the cancer clinic every two weeks for 4 visits and then every 4 weeks for 2 visits; a final visit occurs at week 24. At each visit measurements and quality of life questionnaires are done. It is expected that all patients will be fitted for a compression garment at the beginning of the study prior to randomization and will wear the sleeve on a daily basis for the 24 weeks of the study.

For information on how you can participate in this study contact:

Lyn Kligman, RN, MN, ACNP
Nurse Practitioner, Breast Disease Site Team
Supportive Care, London Regional Cancer Program
790 Commissioners Rd. East, London, ON
N6A 4L6 Canada
E-mail: lyn.kligman@lhsc.on.ca